Japanese haemodialysis anaemia management practices and outcomes (1999-2006): Results from the DOPPS

Nephrology Dialysis Transplantation

Volumn 23, Issue 11, 2008, Pages 3643-3653

  Akizawa, Tadao ^a   Pisoni, Ronald L ^b   Akiba, Takashi ^c   Saito, Akira ^d   Fukuhara, Shunichi ^e   Asano, Yasushi ^f   Hasegawa, Takeshi ^e,g   Port, Friedrich K ^b   Kurokawa, Kiyoshi ^h  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f JICHI MEDICAL UNIVERSITY   (Japan)

^g SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anaemia; DOPPS; Hospitalization; Mortality; Quality of life

Indexed keywords

ANTIANEMIC AGENT; CHONDROITIN SULFATE IRON; CIDEFERRON; ERYTHROPOIETIN; FERRICON; HEMOGLOBIN; IRON; IRON SACCHARATE; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; JAPANESE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SUPINE POSITION;

AGED; ANEMIA; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HOSPITALIZATION; HUMANS; IRON; JAPAN; KIDNEY DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK MANAGEMENT; TREATMENT OUTCOME;

EID: 54149103320     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn346     Document Type: Article

References (32)

1. Patient Registration Committee, Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan as of 31 December 2004. Ther Apher Dial 2006; 10: 476-497
2. Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277
3. Held PJ, Brunner F, Odaka M et al. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982-1987. Am J Kidney Dis 1990; 15: 451-457
4. Valderrabano F. Renal replacement therapy. What are the differences between Japan and Europe? Nephrol Dial Transplant 1996; 11: 2151-2153
5. Saran R, Bragg-Gresham J, Levin NW et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006; 69: 1222-1228
6. Saran R, Pisoni RL, Weitzel WF. Epidemiology of vascular access for hemodialysis and related practice patterns. Contrib Nephrol 2004; 142: 14-28
7. Pifer TB, McCullough KP, Port FK et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002; 62: 2238-2245
8. Collins AJ, Li S, St Peter W et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol 2001; 12: 2465-2473
9. Ofsthun N, Labrecque J, Lacson E et al. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int 2003; 63: 1908-1914
10. Pisoni RL, Bragg-Gresham JL, Young EW et al. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 94-111
11. Gejyo F, Saito A, Akizawa T et al. 2004 Japanese society for dialysis therapy guidelines for renal anemia in chronic hemodialysis patients. Ther Apher Dial 2004; 8: 443-459
12. Pisoni RL, Gillespie BW, Dickinson DM et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis 2004; 44(Suppl 2): S7-S15
13. Young EW, Goodkin DA, Mapes DL et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int 2000; 57(Suppl 74): S74-S81
14. Klein J, Moeschberger M. Survival Analysis Techniques for Censored and Truncated Data. New York: Springer, 1997, 416-418
15. SAS Institute. SAS/STAT User's Guide, Version 8, Vol. 2. Cary, NC: SAS Institute, 2000
16. Nakai S, Niizato T, Shinoda T et al. An overview of dialysis treatment in Japan as of Dec. 31, 2001. J Jpn Soc Dial Ther 2003; 36: 1-31
17. Inagaki H, Kuroda M, Watanabe S et al. Changes in major blood components after adopting the supine position during haemodialysis. Nephrol Dial Transplant 2001; 16: 798-802
18. Jacob G, Raj S, Ketch T et al. Postural pseudoanemia: posture-dependent change in hematocrit. Mayo Clin Proc 2005; 80: 611-614
19. Hinghofer-Szalkay H, Haas G, Oser H et al. Monitoring fluid shifts in humans: application of a new method. Aviat Space Environ Med 1989; 60: 23-28
20. Fawcett JK, Wynn V. Effects of posture on plasma volume and some blood constituents. J Clin Pathol 1960; 13: 304-310
21. Bjerkhoel P, Lindgren P, Lundvall J. Protein loss and capillary protein permeability in dependent regions upon quiet standing. Acta Physiol Scand 1995; 154: 311-320
22. Lundvall J, Bjerkhoel P, Quittenbaum S et al. Rapid plasma volume decline upon quiet standing reflects large filtration capacity in dependent limbs. Acta Physiol Scand 1996; 158: 161-167
23. Hirasawa Y, Suzuki M, Itami N et al. Maintenance hematocrit levels and mortality in hemodialysis patients with renal anemia receiving recombinant human erythropoietin (rHuEPO) treatment (rHuEPO survey). J Jpn Soc Dial Ther 2003; 36: 1265-1272
24. Akizawa T, Young EW, Maroni BJ et al. Nutritional status across three continents: the dialysis outcomes and practice patterns study (Abstract). J Am Soc Nephrol 2000; 11: 254A-255A
25. Combe Ch, Pisoni RL, Port FK et al. Dialysis outcomes and practice patterns study: données sur l'utilisation des cathéters veineux centraux en hémodialyse chronique. Nephrologie 2001; 22: 379-384.
26. Robinson BM, Joffe MM, Berns JS et al. Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time. Kidney Int 2005; 68: 2323-2330
27. Locatelli F, Pisoni RL, Combe C et al. Anaemia in haemodialysis patients of five European countries: association with morbidity andmortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 121-132
28. Wolfe RA, Hulbert-Shearon TE, Ashby VB et al. Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002. Am J Kidney Dis 2005; 45: 127-135
29. Singh AK, Szczech L, Tang KL et al. Correction of anemia with Epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
30. Mapes DL, Bragg-Gresham JL, Bommer J et al. Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44(Suppl 2): 54-60
31. Mapes DL, Lopes AA, Satayathum S et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003; 64: 339-349
32. Fukuhara S, Lopes AA, Bragg-Gresham JL et al. Health-related quality of life among dialysis patients on three continents: the dialysis outcomes and practice patterns study. Kidney Int 2003; 64: 1903-1910